N-[3-[2-[3-(4-chlorophenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]ethynyl]-2,4-difluorophenyl]pyridine-3-sulfonamide

C25H14ClF2N5O2S — CID 122179534

IUPACN-[3-[2-[3-(4-chlorophenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]ethynyl]-2,4-difluorophenyl]pyridine-3-sulfonamide
SMILESO=S(=O)(Nc1ccc(F)c(C#Cc2cnc3n[nH]c(-c4ccc(Cl)cc4)c3c2)c1F)c1cccnc1
InChIInChI=1S/C25H14ClF2N5O2S/c26-17-6-4-16(5-7-17)24-20-12-15(13-30-25(20)32-31-24)3-8-19-21(27)9-10-22(23(19)28)33-36(34,35)18-2-1-11-29-14-18/h1-2,4-7,9-14,33H,(H,30,31,32)
InChIKeyHJYQHYRYGCMEJS-UHFFFAOYSA-N
MW521.94 g/mol
LogP5.15
Rot. Bonds4

About N-[3-[2-[3-(4-chlorophenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]ethynyl]-2,4-difluorophenyl]pyridine-3-sulfonamide

N-[3-[2-[3-(4-chlorophenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]ethynyl]-2,4-difluorophenyl]pyridine-3-sulfonamide (PubChem CID 122179534) has the molecular formula C25H14ClF2N5O2S and a molecular weight of 521.94 g/mol. Its IUPAC name is N-[3-[2-[3-(4-chlorophenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]ethynyl]-2,4-difluorophenyl]pyridine-3-sulfonamide.

Molecular Properties

Compound NameN-[3-[2-[3-(4-chlorophenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]ethynyl]-2,4-difluorophenyl]pyridine-3-sulfonamide
PubChem CID122179534
Molecular FormulaC25H14ClF2N5O2S
Molecular Weight521.94 g/mol
Exact Mass521.05
IUPAC NameN-[3-[2-[3-(4-chlorophenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]ethynyl]-2,4-difluorophenyl]pyridine-3-sulfonamide
SMILESO=S(=O)(Nc1ccc(F)c(C#Cc2cnc3n[nH]c(-c4ccc(Cl)cc4)c3c2)c1F)c1cccnc1
InChIInChI=1S/C25H14ClF2N5O2S/c26-17-6-4-16(5-7-17)24-20-12-15(13-30-25(20)32-31-24)3-8-19-21(27)9-10-22(23(19)28)33-36(34,35)18-2-1-11-29-14-18/h1-2,4-7,9-14,33H,(H,30,31,32)
InChIKeyHJYQHYRYGCMEJS-UHFFFAOYSA-N
XLogP5.15
TPSA100.63 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms36
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500521.94
LogP ≤ 55.15
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze N-[3-[2-[3-(4-chlorophenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]ethynyl]-2,4-difluorophenyl]pyridine-3-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[3-[2-[3-(4-chlorophenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]ethynyl]-2,4-difluorophenyl]pyridine-3-sulfonamide?
The IUPAC name of N-[3-[2-[3-(4-chlorophenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]ethynyl]-2,4-difluorophenyl]pyridine-3-sulfonamide (CID 122179534) is N-[3-[2-[3-(4-chlorophenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]ethynyl]-2,4-difluorophenyl]pyridine-3-sulfonamide.
What is the SMILES notation for N-[3-[2-[3-(4-chlorophenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]ethynyl]-2,4-difluorophenyl]pyridine-3-sulfonamide?
The canonical SMILES for N-[3-[2-[3-(4-chlorophenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]ethynyl]-2,4-difluorophenyl]pyridine-3-sulfonamide is O=S(=O)(Nc1ccc(F)c(C#Cc2cnc3n[nH]c(-c4ccc(Cl)cc4)c3c2)c1F)c1cccnc1.
What is the InChIKey of N-[3-[2-[3-(4-chlorophenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]ethynyl]-2,4-difluorophenyl]pyridine-3-sulfonamide?
The InChIKey is HJYQHYRYGCMEJS-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H14ClF2N5O2S/c26-17-6-4-16(5-7-17)24-20-12-15(13-30-25(20)32-31-24)3-8-19-21(27)9-10-22(23(19)28)33-36(34,35)18-2-1-11-29-14-18/h1-2,4-7,9-14,33H,(H,30,31,32).
What are the key properties of N-[3-[2-[3-(4-chlorophenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]ethynyl]-2,4-difluorophenyl]pyridine-3-sulfonamide?
N-[3-[2-[3-(4-chlorophenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]ethynyl]-2,4-difluorophenyl]pyridine-3-sulfonamide has a molecular weight of 521.94 g/mol, XLogP of 5.15, 4 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[2-[3-(4-chlorophenyl)-2H-pyrazolo[3,4-b]pyridin-5-yl]ethynyl]-2,4-difluorophenyl]pyridine-3-sulfonamide is sourced from PubChem (CID 122179534), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).